Chronic Lymphocytic Leukemia
It has been resently reported that Rituximab Improves outcomes for Patients With Chronic Lymphocytic Leukemia.This basically means in addition to regular chemotherapy patients will be have this drug to help them beat the cancer.This fiding follows clinical trials of some 817 patients.Furthe deals can bee found in an article from the NCI Cancer Bulletin, vol. 5/no. 25, Dec. 16, 2008 or go to
http://www.cancer.gov for details on the trial.
No comments:
Post a Comment